AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Guardant Health, Inc. Common Stock
XNAS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG006D97VZ8
167.47▲ 1.91 (1.15%)
As of 2026-10-09
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
165.56
Day's Range
166.03 – 170.81
52-Week Range
61.00 – 191.05
Volume
1.5M
Avg Volume
1.9M
Share Statistics
Shares Outstanding
Employees
2,506
Exchange
XNAS
Listed
2018-10-04
Share count as of July 24, 2026

Guardant Health, Inc. Common Stock (GH) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Guardant Health, Inc. Common Stock (GH)
What is Guardant Health, Inc. Common Stock's Market Cap?
Guardant Health, Inc. Common Stock's Market Cap is $22.5B, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Enterprise Value?
Guardant Health, Inc. Common Stock's Enterprise Value is $22.9B, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Price / Sales?
Guardant Health, Inc. Common Stock's Price / Sales is 19.0×, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's EV / Revenue?
Guardant Health, Inc. Common Stock's EV / Revenue is 19.4×, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's EV / EBITDA?
Guardant Health, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Revenue (TTM)?
Guardant Health, Inc. Common Stock's Revenue (TTM) is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Net Income (TTM)?
Guardant Health, Inc. Common Stock's Net Income (TTM) is -$453.4M, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's EBITDA?
Guardant Health, Inc. Common Stock's EBITDA is -$431.8M, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's Diluted EPS (TTM)?
Guardant Health, Inc. Common Stock's Diluted EPS (TTM) is -3.38, based on as-reported figures from SEC (XBRL) filings.
What is Guardant Health, Inc. Common Stock's EBITDA Margin?
Guardant Health, Inc. Common Stock's EBITDA Margin is -36.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · GHAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+44.3%+48.3%+39.4%+38.5%
Costs and operating expenses:
Cost of revenue
Research and development expense
Sales and marketing expense
General and administrative expense
Total costs and operating expenses
% of revenue138.5%140.2%143.0%137.3%
Loss from operations
% of revenue-38.5%-40.2%-43.0%-37.3%
Interest income
Interest expense
Other income (expense), net
Loss before provision for income taxes
Provision for income taxes
Net loss
% of revenue-35.9%-37.2%-45.7%-35.0%
Net loss per share, basic (in usd per share)
Net loss per share, diluted (in usd per share)